Psychedelics

Saturday, March 12, 2022 at 2:30pm EST

Past Event

Neuroplasticity: it’s what our brains do. We alter our minds when we engage with the world and with the people in it. But, of course, when we think of “mind altering drugs” we refer to something else. That there might be a shortcut, a wormhole, a portal to some new and improved state of mind has long held our fascination. Yes, that includes alcohol, but while alcohol can affect mood and anxiety and augment sociability, there is something especially appealing about opening a window onto a whole new view of reality itself. Hence the new question born in the 1960’s: “are you experienced?’.

Psychedelics have been featured and feared, romanticized and reviled, lauded and suspected since the earliest epochs of human history. In many tribal ceremonies certain substances with “mind expanding” properties were invoked as communal invitations toward the transcendent. In battle, various plants, herbs, and potions were reputed to make warriors assassins, berserkers, or heroes.

From Greek roots meaning “mind manifesting,” psychedelic refers to a range of mind, mood, and consciousness altering effects – cognitive, perceptual, emotional, and behavioral – deriving from a varied array of compounds. Following the 60’s “turn on, tune in, drop out” popularity of recreational psychedelics, by the early 1970’s it was the risks associated with psychedelics that gained a hold on popular opinion and on the research community.

Times are a changing. With renewed interest, medical research is now exploring psychedelics for the treatment of mental illness, pain management and mental soothing in terminal states. With care given to providing a safe physical space and emotional support throughout, psychedelics can create feelings of union and of breaking free from time and space, often accompanied by visual hallucinations, illusions, and synesthesia. But, in “micro-doses,” doses too low to bring on a “trip,” hallucinogens are now being studied and in some instances found to ameliorate the suffering of PTSD patients, to treat obsessive-compulsive symptoms, body dysmorphic disorder, anorexia nervosa, headache, and substance abuse.

Medical alchemists believed their mixtures could act as poison or panacea. From communal traditions and now clinical research, hope is emerging that there is something in psychedelics that can help to sooth suffering souls and provide safe and effective treatment of some neuropsychiatric disorders.

Participants:

Patricia Dailey

Associate Professor of English and Comparative Literature, Columbia University

Patricia Dailey is an Associate Professor of English and Comparative Literature at Columbia University, Co-Chair of the Affect Studies University Seminar, the Gender and Sexuality Studies Council, and the Colloquium for Early Medieval Studies.  Her book Promised Bodies: Time, Language, and Corporeality in Medieval Women’s Mystical Texts (Columbia University Press, 2013) looks at the way women’s mystical… read more »

Elias Dakwar

Associate Professor, Clinical Psychiatry, Columbia University

Elias Dakwar, MD is an Associate Professor at Columbia University College of Physicians and Surgeons, and a board-certified addiction and general psychiatrist. He has been researching novel treatments for addictions for over a decade, with the support of several grants from the National Institutes of Health. A special focus of his research has been evaluating… read more »

Neşe Devenot

Postdoctoral Associate, Institute for Research in Sensing (IRiS) University of Cincinnati
Affiliate Scholar, Center for Psychedelic Drug Research & Education (CPDRE), Ohio State University
Medicine, Society & Culture Research Fellow, Psymposia.

View Papers / Presentations »

Neşe Devenot, PhD (she/they) is a Postdoctoral Associate at the Institute for Research in Sensing (IRiS) at the University of Cincinnati; an Affiliate Scholar at the Center for Psychedelic Drug Research & Education (CPDRE) at The Ohio State University; and the Medicine, Society & Culture Research Fellow with Psymposia. She previously completed a postdoctoral fellowship… read more »

Alex Kwan

Associate Professor, Department of Psychiatry, Yale University

View Papers / Presentations »

Alex Kwan is a neuroscientist whose work is focused on the neurobiology of antidepressants. He is known for using sophisticated optical imaging methods to study how drugs such as ketamine and psilocybin modify the structure and function of brain circuitry. His research has been published in top peer-reviewed journals including Neuron, Nature Neuroscience, and Biological… read more »

Stephen Ross

Research Associate Professor, Psychiatry and Child & Adolescent Psychiatry, NYU Grossman School of Medicine

View Papers / Presentations »

Stephen Ross, MD, is Research Associate Professor of Psychiatry and Child & Adolescent Psychiatry at the NYU Grossman School of Medicine. Dr. Ross is a founding member of the NYU Psychedelic Research Group and is currently associate director of the NYU Langone Health (NYULH) Center for Psychedelic Medicine and director of the NYULH Psychedelic Medicine… read more »

Leave a Reply

Your email address will not be published. Required fields are marked *

Leave the field below empty!